Back to Results
First PageMeta Content
SEC filings / Becton Dickinson / Healthcare / Regulation S-K / BD / Health care in the United States / CareFusion / Patient safety / Form 10-K / Medicine / Health / Medical equipment


As filed with the Securities and Exchange Commission on November 26, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C[removed]Form 10-K
Add to Reading List

Document Date: 2014-12-16 19:53:16

Open Document

File Size: 298,45 KB

Share Result on Facebook

City

New York / Triangle Park / Franklin Lakes / /

Company

BD Diagnostics / GenCell Biosystems / BECTON / DICKINSON AND COMPANY / Definitive Agreement / Distribution BD / BD Biosciences BD Biosciences / BD Biosciences / ISO Quality Systems / International Operations BD / New York Stock Exchange Securities / BD Diagnostics BD Diagnostics / Regulation BD / CareFusion Corporation / /

Continent

Europe / Africa / /

Country

Puerto Rico / Hungary / Netherlands / France / Japan / Pakistan / Brazil / Canada / United Kingdom / China / India / Germany / Mexico / United States / Singapore / Spain / Ireland / /

Currency

USD / /

Event

M&A / Funding / General or Shareholder Meeting / Product Issues / Reorganization / Product Recall / Environmental Issue / /

Facility

Mine Safety Disclosures / /

IndustryTerm

quality-driven healthcare / government healthcare spending / retail pharmacies / needle-free injection technology / foreign subsidiaries / medical technology field / transportation / healthcare payment systems / blood collection products / flu diagnostic products / healthcare institutions / medical device suppliers / oil-based components / pharmaceutical industry / laboratory products / paper products / tuberculosis culturing systems / insurance / alternate manufacturing facilities / liquid-based cytology systems / healthcare fraud / biological analysis protocols / reagent systems / agricultural products / closed-system transfer devices / infusion therapy products / energy / medical technology / quality management / plastics / healthcare coverage / healthcare industry / healthcare programs / medical technology area / clinical tools / drug susceptibility systems / technology escrow accounts / integrated health delivery networks / manufacturing / health insurance plans / laboratory equipment / healthcare providers / certain medical devices / biopharmaceutical manufacturing / biotechnology / prefillable syringe systems / medical technology industry / instrument systems / medical devices / medical technology marketplace / information technology systems / proprietary technologies / intellectual property / payment systems / manufacturing sites / manufacturing locations / food microbiology laboratories / medical technology products / health insurance coverage / treatment of diabetes / prefillable drug delivery systems / pharmaceutical / healthcare / oil / diagnostic systems / brand blood collection products / plated media / Federal healthcare reform / safety-engineered and auto-disable devices / energy costs / healthcare workers / drug/device / technology assessments / medication management / molecular testing systems / cell culture media supplements / law focuses / manufacturing operations / healthcare settings / petrochemical products / patient safety solutions / /

MedicalCondition

product seizures / cancer / diabetes / diseases / cuts / seasonal diseases / flu / infections / influenza / cancers / disease / infectious diseases / tuberculosis / /

MedicalTreatment

drug delivery systems / alternative therapies / catheters / /

Organization

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington / D.C. / U.S. government / Joint Federal Committee in Germany / Audit Committee / National Development and Reform Commission in China / Medicare / Ministry for Health / Labor and Welfare in Japan / Science / Marketing / Innovation and Technology Committee / Securities and Exchange Commission / National Health Service / Ministry of Health / Executive Committee / Corporate Governance and Nominating Committee / Compensation and Benefits Committee / federal government / U.S. Food and Drug Administration / I.R.S. / officers of the Registrant / /

/

Position

Corporate Secretary / Director Independence / bundled physician / Governor / /

Product

product / /

ProvinceOrState

New Jersey / North Carolina / New / /

Region

Middle East / Western Europe / Latin America / Asia Pacific / /

Technology

information technology / genotyping / drug delivery / biological analysis protocols / antibodies / biotechnology / needle-free injection technology / /

URL

www.sec.gov / www.bd.com/investors/corporate_governance / www.bd.com/investors / www.bd.com / /

SocialTag